Results 11 to 20 of about 774,384 (405)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. [PDF]
New England Journal of Medicine, 2019 BACKGROUND Interstitial lung disease (ILD) is a common manifestation of systemic sclerosis and a leading cause of systemic sclerosis-related death. Nintedanib, a tyrosine kinase inhibitor, has been shown to have antifibrotic and antiinflammatory effects ...
O. Distler +14 more
semanticscholar +5 more sources
In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011 [PDF]
, 2015 Rationale: Surgical lung biopsy can help to determine a specific diagnosis in interstitial lung disease, but has associated risks. Most currently available mortality data are derived from case series and may not be generalizable to broader populations.
John Hutchinson +3 more
openalex +4 more sources
Annals of the American Thoracic Society, 2021 Rationale: The natural history of recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unknown. Because fibrosis with persistent physiological deficit is a previously described feature of patients recovering from similar ...
K. Myall +10 more
semanticscholar +1 more source
A multidisciplinary approach to the diagnosis of antisynthetase syndrome
Frontiers in Medicine, 2022 Antisynthetase syndrome is a subtype of idiopathic inflammatory myopathy, strongly associated with the presence of interstitial lung disease. Diagnosis is made by identifying myositis-specific antibodies directed against aminoacyl tRNA synthetase, and ...
Matthew Wells +10 more
doaj +1 more source
European Respiratory Journal, 2022 Background Progressive fibrosing interstitial lung disease (PF-ILD) is characterised by progressive physiological, symptomatic and/or radiographic worsening. The real-world prevalence and characteristics of PF-ILD remain uncertain.
N. Hambly +27 more
semanticscholar +1 more source
Interstitial lung disease [PDF]
European Respiratory Review, 2014 Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidity and mortality. Knowledge achieved in recent years has resulted in the publication of the new classification of idiopathic interstitial pneumonias, according to which there are three groups: major, rare and unclassified.
Antoniou, Katerina M. +5 more
openaire +4 more sources
Respiratory Research, 2023 Introduction Interstitial lung disease (ILD) may be difficult to distinguish from other respiratory diseases due to overlapping clinical presentation. Recognition of ILD is often late, causing delay which has been associated with worse clinical outcome ...
Iris G. van der Sar +6 more
doaj +1 more source
European Respiratory Review, 2021 Rheumatoid arthritis (RA) is a systemic inflammatory disorder, with the most common extra-articular manifestation of RA being lung involvement. While essentially any of the lung compartments can be affected and manifest as interstitial lung disease (ILD),
S. Kadura, G. Raghu
semanticscholar +1 more source
Arthritis & Rheumatology, 2022 To analyze the efficacy and safety of nintedanib in patients with fibrosing autoimmune disease–related interstitial lung diseases (ILDs) with a progressive phenotype.
E. Matteson +14 more
semanticscholar +1 more source
Predictors and changes of physical activity in idiopathic pulmonary fibrosis
BMC Pulmonary Medicine, 2022 Background Different clinical predictors of physical activity (PA) have been described in idiopathic pulmonary fibrosis (IPF), but studies are lacking evaluating the potential role of muscle strength and anxiety and depression symptoms in PA limitation ...
Diana Badenes-Bonet +15 more
doaj +1 more source